Table 2 HU liver, HU spleen, and HU Liver/HU spleen ratio among the studied groups
From: The effect of hepatic steatosis on 18F-FDG uptake in PET-CT examinations of cancer Egyptian patients
Parameters | Fatty liver (n = 25) | Non-fatty liver (n = 25) | Test of Sig | p value |
|---|---|---|---|---|
HU liver | ||||
Min.–Max | 7.0–45.0 | 47.0–57.0 | t = 10.070 |  < 0.001* |
Mean ± SD | 29.68 ± 10.09 | 51.32 ± 3.68 | ||
Median | 30.0 | 50.0 | ||
HU spleen | ||||
Min.–Max | 36.0–51.0 | 27.0–49.0 | U = 293.50 | 0.711 |
Mean ± SD | 41.80 ± 4.02 | 44.11 ± 5.05 | ||
Median | 41.0 | 42.0 | ||
HU liver/HU spleen ratio | ||||
Min.–Max | 0.18–0.96 | 0.53–1.96 | U = 19.0 |  < 0.001* |
Mean ± SD | 0.70 ± 0.21 | 1.26 ± 0.23 | ||
Median | 0.76 | 1.27 | ||